News for Healthier Living

A Nuclear Target to Revive Anti-Tumor Immunity

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A--all-trans retinoic acid--compromises both the body's normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine.

January 5, 2026


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025